Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Drug Manufacturers
Citigroup Inc's Strategic Reduction in Eagle Pharmaceuticals Inc Shares
Nov 13, 2024
Drug Manufacturers
Morgan Stanley Lowers AbbVie's Target Price to $224, Maintains "Overweight" Rating (ABBV)
Nov 13, 2024
Drug Manufacturers
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges
Despite a 6% revenue increase and strategic investments, Organogenesis Holdings Inc (ORGO) faces rising expenses and market uncertainties. Nov 13, 2024
Drug Manufacturers
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic Acquisitions Propel Growth
Eton Pharmaceuticals Inc (ETON) reports a milestone quarter with significant sales growth, strategic acquisitions, and promising pipeline advancements. Nov 13, 2024
Drug Manufacturers
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments Amid Challenges
AstraZeneca PLC (AZN) reports a 21% revenue increase and upgrades full-year guidance, while navigating potential headwinds in China and the US market. Nov 13, 2024
Drug Manufacturers
Ascend Wellness Holdings Inc (AAWH) Q3 2024 Earnings Call Highlights: Strategic Expansion Amidst Market Challenges
Ascend Wellness Holdings Inc (AAWH) reports steady revenue growth and outlines plans for cost savings and expansion despite competitive pressures. Nov 13, 2024
Drug Manufacturers
Cronos Group Inc (CRON) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion Amid Market Challenges
Cronos Group Inc (CRON) reports significant revenue growth and improved cash flow, while navigating competitive pressures and regulatory uncertainties. Nov 13, 2024
Drug Manufacturers
Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and Strategic Investments Propel Revenue
Avadel Pharmaceuticals PLC (AVDL) reports robust Q3 performance with $50 million in net revenue and strategic expansions in patient care and market reach. Nov 13, 2024
Drug Manufacturers
Rockwell Medical Inc (RMTI) Q3 2024 Earnings Call Highlights: Record Growth and Strategic Expansion Amid Revenue Challenges
Rockwell Medical Inc (RMTI) reports historic sales and profitability while navigating anticipated revenue declines from its largest customer. Nov 13, 2024
Drug Manufacturers
Suven Pharmaceuticals Ltd (BOM:543064) Q2 2025 Earnings Call Highlights: Strong Pharma CDMO Growth Amidst Revenue Challenges
Suven Pharmaceuticals Ltd (BOM:543064) reports a 12% revenue increase driven by Pharma CDMO growth, despite facing hurdles in specialty chemicals and pending merger approvals. Nov 13, 2024
Drug Manufacturers
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance
OptiNose Inc (OPTN) reports a 3% revenue increase and improved prescription metrics, but adjusts full-year guidance due to slower uptake and operational challenges. Nov 13, 2024
Drug Manufacturers
Hikal Ltd (BOM:524735) Q2 FY25 Earnings Call Highlights: Strong Revenue Growth Amidst Sector Challenges
Hikal Ltd (BOM:524735) reports a 29% revenue increase and strategic advancements, while navigating pricing pressures and debt concerns. Nov 13, 2024
Drug Manufacturers
Zydus Lifesciences Ltd (BOM:532321) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Regulatory Challenges
Despite impressive financial performance, Zydus Lifesciences Ltd (BOM:532321) faces compliance issues and increased R&D expenses impacting profitability. Nov 13, 2024
Drug Manufacturers
Morepen Laboratories Ltd (BOM:500288) Q2 2025 Earnings Call Highlights: Strong Profit Growth and Strategic Expansion
Morepen Laboratories Ltd (BOM:500288) reports a 64% increase in profit after tax and outlines ambitious growth plans for its medical devices and export segments. Nov 13, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers